SNT
Click for more information
8.33% 2.2¢ syntara limited

Ann: Boehringer Initiating Phase 2a Study Diabetic Retinopathy, page-13

  1. hondamotorco
    201 Posts.
    clock Created with Sketch.
    08/09/17
    14:44
    Post #: 27091101
    BI have got to 20% without much upward movement in price- they'll use that as justification for a low ball offer probably not much over the 50c mark. They're at 20% already so if they're going to strike i think it will be very very soon. They've been holding the price down imho for this very reason. Good luck all its worth a lot more here hoping the majority realise that
    PXS Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.2¢ 		Change
-0.002(8.33%) 		Mkt cap ! $26.26M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $4 197

Buyers (Bids)

No. Vol. Price($)
5 383913 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 29356 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.